Clinical Trials Browser

OTHER × Carcinoma, Non-Small-Cell Lung × bavituximab × Clear all

NCT01323062 2018-12-04

Bavituximab Plus Carbo and Pemetrexed in Chemo-Naive Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) Subjects

Phase 1 Completed

Carcinoma, Non-Small-Cell Lung